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Brief Definit ive Report
T cells have evolved to quickly react to potentially 
dangerous microbes by recognizing pathogen-
derived peptide (p)-MHC complexes displayed 
on antigen-presenting cells, in particular DCs. 
Because T cells are selected in the thymus for 
their ability to recognize self-pMHC complexes 
(Morris and Allen, 2012) and numerous self-
reactive T cells are released into the periphery 
(Su et al., 2013), peripheral tolerance education 
is critical to avoid activation of autoreactive 
T cells. Studies using intravital two-photon mi-
croscopy (2PM) of reactive PLNs have shed light 
on the dynamic T cell–DC interactions and their 
correlation with full versus curtailed T cell acti-
vation and tolerance induction. The amount of 
cognate pMHC complexes on activated DCs is 
critical in determining the transition of a highly 
motile scanning-mode T cell to an immotile, 
stably interacting one (Cahalan and Parker, 2006; 
Henrickson and von Andrian, 2007; Bajénoff 
and Germain, 2007). Such stable T cell–DC 
interactions (>8h) are a prerequisite for full ef-
fector T cell differentiation (Rachmilewitz and 
Lanzavecchia, 2002). Thus, in presence of high 
amounts of cognate pMHC on activated DCs, 
T cells decelerate rapidly, whereas T cells show 
a motile DC sampling behavior when cognate 
pMHC levels are low. Altered peptide ligands 
(APLs) with reduced affinity for a given TCR 
also decrease the length of T cell–DC interactions, 
limiting T cell activation. Under tolerogenic con-
ditions (i.e., in the absence of co-stimulation), 
2PM studies uncovered shortened T cell–DC 
interactions (Hugues et al., 2004) although this is 
still controversial (Shakhar et al., 2005). Similarly, 
the presence of regulatory T (T reg) cells reduces 
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Interactions between dendritic cells (DCs) and T cells control the decision between activa-
tion and tolerance induction. Thromboxane A2 (TXA2) and its receptor TP have been sug-
gested to regulate adaptive immune responses through control of T cell–DC interactions. 
Here, we show that this control is achieved by selectively reducing expansion of low-avidity 
CD4+ T cells. During inflammation, weak tetramer-binding TP-deficient CD4+ T cells were 
preferentially expanded compared with TP-proficient CD4+ T cells. Using intravital imaging 
of cellular interactions in reactive peripheral lymph nodes (PLNs), we found that TXA2 led 
to disruption of low- but not high-avidity interactions between DCs and CD4+ T cells. Lack 
of TP correlated with higher expression of activation markers on stimulated CD4+ T cells 
and with augmented accumulation of follicular helper T cells (TFH), which correlated with 
increased low-avidity IgG responses. In sum, our data suggest that tonic suppression of 
weak CD4+ T cell–DC interactions by TXA2–TP signaling improves the overall quality of 
adaptive immune responses.
© 2014 Moalli et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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et al., 2003). In our SPF colony, we observed enlarged mes-
enteric LNs (MLNs), occasionally accompanied by spleno-
megaly, in TP/ mice >3 mo old (unpublished data). We 
therefore evaluated antigen-specific adaptive immune re-
sponses in younger WT and TP/ mice (5–8 wk), which 
displayed normal lymphoid organ size and showed no signs 
of spontaneous lymphocyte activation (unpublished data). 
Because physiological T cell responses involve low- and 
high-avidity TCR T cells (Sabatino et al., 2011), we exam-
ined the role of TP during expansion of Ag-specific CD4+ 
T cells recognizing OVA-derived peptides after s.c. OVA/
CFA immunization (Fig. S1 A). Both WT and TP/ mice 
showed expansion of low- and high-avidity OVA-peptide 
tetramer-positive (OVA tet+) CD4+ T cells on day 8 after 
immunization in draining PLNs (Fig. 1 A). Notably, we 
found a larger increase of OVA tet+ CD4+ T cells in reac-
tive PLNs of TP/ mice as compared with WT mice 
(Fig. S1 B), in particular among the weak-binding OVA 
tet+ low population (Fig. 1 B). When we compared the 
ratio of low- and high-avidity OVA tet+ CD4+ T cells, we 
consistently found in draining PLNs relatively more low-
avidity T cells participating in the immune response in 
TP/ mice compared with WT mice, despite comparable 
TCR expression levels (Fig. 1, C and D). A recent study has 
implicated neutrophil-derived TXA2 in the control of 
T cell responses (Yang and Unanue, 2013). We therefore 
performed OVA/CFA immunization in neutrophil-depleted 
WT and TP/ mice. Similar to nondepleted mice, TP 
deficiency resulted in increased expansion of low-avidity 
CD4+ T cells in PLNs (Fig. 1 E). To rule out an influence 
of different TCR repertoires in WT and TP/ mice on 
expansion of low- and high-avidity CD4+ T cells, we ana-
lyzed their ratio in control versus TP antagonist GR32191B-
treated WT mice after s.c. OVA/CFA immunization. Again, 
we observed a skewing of the adaptive immune response 
toward low-avidity CD4+ T cells in reactive GR32191B-
treated WT PLNs as compared with controls (Fig. 1 F). In 
two independent experiments, the ratio of low- vs. high-
avidity CD4+ T cells from GR32191B-treated mice was 
increased by >30%.
To examine the relevance of TP-dependent tonic signal-
ing in an infection model, we infected WT and TP/ mice 
with lymphocytic choriomeningitis virus (LCMV) Armstrong 
strain. During LCMV Armstrong infection, we observed 
a nonsignificant tendency for increased expansion of gp66-77 
tet+ CD4+ T cells in TP/ as compared with WT spleens 
(8.8 ± 3.3% in WT vs. 14.8 ± 9.1% in TP/ mice; mean ± 
SD), whereas no tet+ CD4+ T cells were observed in PLNs 
(unpublished data). Among the gp66-77 tet+ populations, the 
ratio of low- to high-avidity T cells was strongly skewed to 
the former in TP/ mice (Fig. 1, G–I; and Fig. S1 C), de-
spite comparable CD4+ FoxP3+ T reg cell percentages (not 
depicted). Collectively, the results obtained in sterile and in-
fectious inflammation models suggest that absence of TP 
shapes the differential expansion of low- versus high-avidity 
T cells in a polyclonal repertoire.
T cell–DC interactions and subsequent T cell activation 
(Tadokoro et al., 2006; Tang et al., 2006).
A perhaps counterintuitive recent finding has revealed 
a significant increase in CD8+ T cell immune response avidity 
in presence of T reg cells (Pace et al., 2012). This is due to T reg 
cell–mediated suppression of excessive interactions between 
DCs and CD8+ T cells bearing TCRs with low avidity for 
pMHC complexes. In the absence of T reg cells, uncontrolled 
CCR5 ligand secretion by activated DCs induces attraction 
of bystander TCR clones with low affinity for pMHC com-
plexes, which decreases overall avidity and memory T cell 
generation of the resulting immune response. Whether a 
comparable mechanism also exists to selectively support acti-
vation of high avidity CD4+ T cells by immunoregulatory 
factors is currently unknown.
The short-lived arachidonic acid–derived lipid thrombox-
ane A2 (TXA2) has been suggested to regulate adaptive immune 
responses (Kabashima et al., 2003). Activated DCs and other 
cell types produce TXA2, which binds its G-protein coupled 
receptor TP expressed in thymocytes and naive but not effector/
memory CD4+ and CD8+ T cells. Addition of high amounts 
of the TP agonist I-BOP induces chemokinesis in naive T cells 
and decreases in vitro aggregate formation between T cells 
and DCs, causing reduced T cell activation (Kabashima et al., 
2003). Combined with the observation that TXA2 levels rap-
idly rise in reactive PLN during immune responses (Moore 
et al., 1989), these data suggest a model where TXA2 may act 
as a general suppressor of T cell–DC interactions. In line with 
this hypothesis, aged TP-deficient T cells develop lymphoid 
hyperplasia and high antibody titers (Kabashima et al., 2003). 
Yet, it has remained unknown how TXA2 signaling affects 
dynamic CD4+ T cell interactions with DC displaying vary-
ing pMHC abundance and affinity in vivo, and how this im-
pacts avidity patterns of responding T cells.
Here, we show that during sterile and microbial inflam-
mation, absence of TP resulted in increased expansion of 
low-avidity CD4+ T cells. Using 2PM imaging of cellular inter-
actions in reactive PLNs, we report that paracrine TXA2 
signaling preferentially disrupted low-avidity interactions be-
tween DCs and OT-II CD4+ T cells induced by low cognate 
pMHC levels or low-affinity peptide. As a consequence, TP/ 
OT-II CD4+ T cells show increased expression of early activa-
tion markers, as well as augmented accumulation of follicular 
helper T cells (TFH) compared with WT OT-II CD4+ cells. 
High numbers of TP/ TFH correlated with increased low-
avidity IgG production, thus thwarting the overall quality 
of the adaptive immune response. In sum, our data uncover 
a previously unappreciated contribution of a tolerance- 
inducing mechanism for preferential activation of high avid-
ity CD4+ T cells.
RESULTS AND DISCUSSION
Lack of TP lowers overall polyclonal CD4+  
T cell avidity during inflammation
TP/ mice were reported to develop lymphadenopathy and 
increasing circulating Ig levels with age (>26 wk; Kabashima 
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the absence of TP agonist I-BOP, similar proliferation and 
activation marker up-regulation after in vitro stimulation 
(unpublished data). Using these cells as tools in combination 
with DCs pulsed with varying OVA peptide concentrations, 
we performed 2PM of draining PLNs to directly investigate 
the effect of TXA2-TP signaling during initial T cell–DC 
interactions in vivo. As reported for T cell migration in ex-
planted PLNs (Huang et al., 2007), lack of TP did not influ-
ence the speed, directionality, and motility coefficient (MC) 
of naive T cells as compared with WT T cells in nonreactive 
PLNs (Fig. 2 A and not depicted), presumably owing to low 
TXA2 levels in steady state. In contrast, activated DCs pulsed 
with 0.1 µM OVA323-339 induced a significantly stronger de-
celeration of TP/ OT-II CD4+ T cell speeds as compared 
TP expression on naive OT-II CD4+ T cells impairs  
in vivo interactions with DCs bearing low amounts  
or weak agonist pMHC complexes
The data obtained in our inflammation models prompted us 
to examine how TP influenced dynamic CD4+ T cell–DC 
interactions in vivo. We therefore generated TP/ OT-II 
CD4+ T cells recognizing the OVA323-339 peptide. Despite high 
expression of TP in thymocytes, TP/ OT-II CD4+ T cells 
displayed a bona fide naive phenotype characterized by high 
L-selectin/low CD44 expression and CD3 levels similar to 
WT OT-II CD4+ T cells (unpublished data). Furthermore, 
WT and TP/ OT-II CD4+ T cells formed comparable 
in vitro immunological synapses (IS) defined by LFA-1 and 
PKC translocation to OVA323-339-pulsed DCs and showed, in 
Figure . Absent TP signaling results in 
enhanced expansion of low-avidity CD4+ 
T cells during inflammation. (A–D) WT and 
TP/ mice were immunized with OVA/CFA, 
and OVA-specific CD4+ T cells in the draining 
peripheral LNs (PLNs) were analyzed on day 8 
by tetramer staining. (A) Representative flow 
cytometry plots of polyclonal WT versus TP/ 
CD4+ T cells after gating on CD4+ T cells and 
staining with control or OVA-specific tetra-
mers. Numbers indicate percentage of CD4+  
T cells in low and high tet+ gates. (B) Percent-
ages of low and high OVA tet+ CD4+ T cells. 
(C) Ratio of low versus high OVA tet+ CD4+  
T cells. (D) MFI of CD3 expression on OVA tet+ 
WT and TP/ T cells. (E and F) Mice were 
immunized as in A–D. Neutrophils were de-
pleted by injecting anti-Ly6G antibody (1A8) 
on day 1 (E) or mice were treated with  
a selective thromboxane receptor antagonist 
(GR32191B) for 9 d starting 1 d before immu-
nization (F). Ratio of low versus high OVA tet+ 
CD4+ T cells in draining PLNs at day 8 are 
shown. (G–I) WT and TP/ were infected with 
LCMV Armstrong, and CD4+ T cells in spleen 
were analyzed on day 8. (G) Representative 
flow cytometry plots of control and gp66-77 
tet+ CD4+ T cells. Numbers indicate percent-
age of 7AAD CD4+ T cells in low and high 
tet+ gates. (H) Percentages of low versus high 
gp66-77 tet+ CD4+ T cells. (I) Ratio of low 
versus high gp66-77 tet+ CD4+ T cells. Data in 
B, C, and E are pooled from two independent 
experiments with a total of 4–7 mice per con-
dition and combined staining of each sample 
with two different OVA tetramers, whereas  
D and F show representative data from one  
of two independent experiments with compa-
rable results (3–4 mice/group). Data in G–I are 
pooled from two independent experiments 
with a total of 8 mice/group. Data in B and H 
were analyzed using ANOVA with Sidak’s 
post-test, whereas C–F and I were analyzed 
using the Mann-Whitney test and are shown 
±SEM. **, P < 0.01; ***, P < 0.001.
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pulsed with 10 µM OVA peptide, although TP/ OT-II 
CD4+ T cells still showed an increased arrest coefficient as 
compared with WT OT-II CD4+ T cells (Fig. 2, B and C; 
Video 2).
with WT OT-II CD4+ T cells, accompanied by an in-
crease of the arrest coefficient and a lower MC (Fig. 2, 
B and C; and Video 1). This speed difference disappeared 
when we examined T cell motility in the presence of DCs 
Figure 2. Intravital imaging of WT ver-
sus TP/ OT-II CD4+ T cell interactions 
with pMHC-loaded DCs. (A–E) Polyclonal 
WT and TP/ T cells were adoptively trans-
ferred in the absence of s.c. injected DCs  
(A) or WT and TP/ OT-II CD4+ T cells were 
transferred in presence of DCs pulsed with 
indicated OVA323-339 or turkey (t)OVA324-340  
(B–E). Single cell speeds and MC of adoptively 
transferred cells (A and B), their arrest coef-
ficient (C) and T cell–DC interaction times 
(E) were monitored by 2PM imaging. D shows 
representative 2PM images of DC interactions 
with WT (arrowheads) and TP/ OT-II CD4+  
T cells (arrows). An encircled HEV is seen in 
the top row. Time is shown in minutes and 
seconds. Bar, 10 µm. Each dot represents one 
track (A–C) or interaction (E). Data in A–C and E 
are pooled from at least two independent 
experiments and were analyzed by Mann-
Whitney test. Red bars indicate median.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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were comparable to those of WT OT-II CD4+ T cells stimu-
lated by 10 µM OVA323-339-pulsed DCs (Fig. 3 B), indicating 
that 100-fold lower pMHC levels were already sufficient to 
induce robust in vivo TP/ OT-II CD4+ T cell activation. 
Extrapolated to a polyclonal T cell population with variable 
TCR repertoire, the data obtained using a monoclonal TCR 
population suggest that the activation threshold for TP/ 
CD4+ T cells bearing low-avidity TCRs is substantially re-
duced as compared with WT CD4+ T cells during inflamma-
tion. Given the abundance of low-avidity T cell clones during 
immune responses (Sabatino et al., 2011), this likely explains 
the substantial expansion of low-avidity CD4+ T cells in the 
absence of TP signaling (Fig. 1).
High TCR binding strength results in the generation of 
follicular helper T cells (TFH; Fazilleau et al., 2009), and TP/ 
mice develop increased circulating antibody titers with age 
(Kabashima et al., 2003). We thus investigated whether the 
absence of TP influenced the generation of TFH 8 d after 
OVA/CFA immunization in mice having received WT and 
TP/ OT-II CD4+ T cells. We found that the TP/ OT-II 
CD4+ T cells had expanded significantly more than WT CD4+ 
T cells (Fig. 4, A and B; and Fig. S1 D), whereas both cell 
populations differentiated similarly into CXCR5high PD-1high 
TFH (Fig. 4, C and D) and showed comparable expression of 
bcl-6 (Fig. 4 E), IL-21 (Fig. 4 F), and ICOS (not depicted). 
The similar percentage of TFH generation in the absence of 
TP—despite increased expansion—likely reflects the constant 
pattern of effector cell differentiation inherent to OT-II 
TCR transgenic CD4+ cells (Tubo et al., 2013). Germinal 
center (GC) B cells showed a parallel increased expansion in 
TP/ as compared with WT OT-II CD4+ T cell recipients 
(Fig. 4, G and H; and Fig. S1 E). Collectively, using a mono-
clonal CD4+ T cell population, we identified a negative reg-
ulatory role of TP for weak T cell–DC interactions induced 
by limited amounts of cognate pMHC or APL presentation. 
The absence of TP on pMHC-specific transferred CD4+ 
T cells sufficed to produce a substantial increase in TFH and, 
as a consequence, GC B cells during inflammation.
Increased TFH numbers in the absence  
of TP correlate with low-affinity IgG production
We investigated the functional consequences of TP/ TFH 
accumulation on the quality of ensuing IgG responses. We 
adoptively transferred WT or TP/ OT-II CD4+ T cells into 
SMARTA mice, in which the majority of CD4+ T cells are 
specific for the LCMVgp61-80 peptide and therefore unable to 
provide B cell help to other epitopes in the first 8 d after im-
munization (Oxenius et al., 1998; and unpublished data). After 
immunization with NP16-OVA, we analyzed on day 8 serum 
titers of high- and low-affinity IgG by ELISA using NP8- or 
NP41-BSA-coated plates, respectively. We found that although 
both WT and TP/ OT-II CD4+ T cells were able to support 
similar titers of high-affinity IgG against NP8-BSA, low-affinity 
anti–NP41-BSA IgG production was substantially increased in 
SMARTA recipients transferred with TP/ OT-II CD4+ 
T cells (Fig. 5, A and B). Finally, we transferred OVA tet+ CD4+ 
When we analyzed the duration of T cell–DC contacts, 
we observed that WT OT-II CD4+ T cells engaged in mostly 
short interactions with DCs pulsed with 0.1 µM OVA323-339, 
with only 38% of observed interactions lasting >20 min (Fig. 2, 
D and E; and Video 3). In contrast, TP/ OT-II CD4+  
T cells engaged longer with 0.1 µM OVA323-339–pulsed DCs, 
with 58% of all observed interactions lasting throughout the 
observation period (P < 0.05). This difference was not observed 
when we quantified contact duration of WT and TP/ OT-II 
CD4+ T cells with DCs pulsed with 10 µM OVA323-339. Under 
these conditions, stable interactions prevailed in both cell 
populations (68 vs. 73% for WT and TP/ OT-II CD4+ T cells, 
respectively; Fig. 2, D and E; and Video 4). At 18–24 h after 
transfer, we observed that both cell populations had detached 
from DCs and moved with similar migration speeds, suggest-
ing that TP mostly controls T cell–DC interactions during 
the first hours of contact or during initial contact formation 
(unpublished data).
In addition to the abundance of cognate pMHC com-
plexes, T cell–DC interactions are regulated by TCR-pMHC 
affinity. To examine this further, we used APL-pulsed DCs 
using 10 µM turkey OVA peptide (tOVA324-340), which yields 
pMHC complexes with lower affinity for the OT-II TCR 
(Gollmer et al., 2009). In 2PM experiments, the majority 
of WT OT-II CD4+ T cells interacted only briefly with 
tOVA324-340-pulsed DCs and continued with high migration 
speeds and low arrest coefficient (Fig. 2, B–E; and Video 5). 
Absence of TP on OT-II CD4+ T cells permitted these cells 
to interact significantly longer with tOVA-pulsed DCs (9 vs. 
25% for WT and TP/ OT-II CD4+ T cells, respectively; P < 
0.01), resulting in decreased migration speeds and increased 
arrest coefficients (Fig. 2, B–E; and Video 6). In sum, our 
2PM imaging experiments suggest a role for TP in restraining 
naive CD4+ T cell–DC interactions when cognate pMHC 
levels or TCR-pMHC affinities are low, in line with a func-
tion of cell-extrinsic tonic regulator. Tonic regulation prevents 
participation of naive lymphocytes in adaptive immune re-
sponses by raising the activation threshold, whereas T reg cells 
often act to dampen already activated T cells and are therefore 
considered reactive regulators in many cases (Germain, 2012).
Increased early OT-II CD4+ T cell activation  
and TFH generation in the absence of TP
We examined the consequences of increased duration of TP/ 
OT-II CD4+ T cell–DC interactions on effector differentia-
tion. 24 h after transfer to recipient mice containing 0.1 µM 
OVA323-339-pulsed DCs, TP/ OT-II CD4+ T cells showed 
increased expression of the early activation markers CD69 
and CD25 as compared with WT OT-II CD4+ T cells (Fig. 3, 
A–C). Higher CD69 and CD25 expression was also observed 
in TP/ OT-II CD4+ T cells after transfer with DCs pulsed 
with 10 µM OVA323-339 (Fig. 3, A–C). This suggests that TP/ 
OT-II CD4+ T cells integrate signals more efficiently than 
TP-proficient cells over a wide range of pMHC densities. 
Notably, CD69 and CD25 expression levels of TP/ OT-II 
CD4+ T cells stimulated by 0.1 µM OVA323-339-pulsed DCs 
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short-lived in these experiments (<5 min), we found occa-
sional long interactions (>20 min) exclusively in the TP/ 
CD4+ T cell subset (unpublished data). However, because 
TP/ OT-II CD4+ T cells show increased expression of acti-
vation markers at early time points and the cognate pMHC 
density on individual B cells was unknown, these data remain 
difficult to interpret. Furthermore, 2PM experiments at later 
time points after immunization showed that TP antagonist 
GR32191B treatment did not reduce speeds of Ag-specific 
CD4+ T cells migrating along FDCs (unpublished data). In line 
with this, TP expression decreases on effector T cells, includ-
ing TFH, and B cells do not express TXA2 synthase and do not 
secrete TXA2 (Immgen database; unpublished data; Kabashima 
et al., 2003). Recent evidence has uncovered that TFH interact 
with GC B cells for only a short period of time, even when 
these cells present high levels of cognate pMHC (Shulman 
et al., 2014). It is therefore conceivable that excessive numbers 
of TFH provide help to numerous GC B cells, which then drives 
production of low-affinity IgG. In line with this concept, TFH 
help for cognate Ag-bearing GC B cells directly correlates with 
T cells isolated from OVA-immunized WT and TP/ mice 
into SMARTA mice and challenged the recipients with NP16-
OVA as above (Fig. S1 F). Again, we observed that mice trans-
ferred with TP/ OVA tet+ CD4+ T cells showed skewing of 
the ensuing IgG response to low-affinity IgG compared with 
WT OVA tet+ CD4+ T cells, as reflected by a substantial 
increase in titers of NP41- but not NP8-BSA–binding IgG 
(Fig. 5 C). In sum, these data support a scenario where absence 
of TP leads to a significant rise in TFH expansion, which has been 
associated with decreased quality of humoral responses (Pratama 
and Vinuesa, 2014). Alternatively, owing to their avid binding 
to cells bearing low pMHC levels, activated TP/ CD4+  
TFH cells, or their precursors, may provide help to B cells with 
low-affinity BCRs. To address this point experimentally, we used 
2PM of HEL-OVA–draining PLNs to examine WT and TP/ 
OT-II CD4+ T cell interactions with HEL-specific MD4 or 
SWHEL B cells at the border between T cell area and B cell fol-
licles, where early CD4+ T cell–B cell interactions (1–3 d after 
immunization) precede ensuing GC reactions (Vinuesa and 
Cyster, 2011). Although most T cell–B cell interactions were 
Figure . TP/ OT-II CD4+ T cells display 
increased activation marker expression as 
compared with WT OT-II CD4+ T cells. 
(A-C) WT and TP/ OT-II CD4+ T cells were 
analyzed by flow cytometry 24 h after adop-
tive transfer in presence of DCs pulsed with 
low (0.1 µM) and high (10 µM) OVA323-339 
concentrations. A shows representative flow 
cytometry plots of CD25 and CD69 expres-
sion. Numbers indicate percent positive cells. 
Percentages and normalized MFI of CD69+ 
(B) and CD25+ (C) transferred WT and TP/ 
OT-II CD4+ T cells are shown. Each dot in  
B and C represents PLNs pooled from one 
mouse. Data are from 2–3 independent 
experiments with a total of 6–8 mice and 
analyzed using repeated measure ANOVA 
with Bonferroni post-test. Bars indicate mean. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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host from autoreactive T cells. How such a balance is achieved 
is not completely understood to date. Although immuno-
suppressive mechanisms have often been considered to gen-
erally hamper immune responses, Pace et al. (2012) have 
uncovered improved CD8+ T cell avidity in the presence of 
T reg cells. Similarly, we report that absence of TP increased 
the numbers of low-avidity CD4+ T cell clones transiting from 
kynapse- to synapse-like interactions with DCs (Bousso, 
2008). In contrast to T reg cells or stromal cell–derived nitric 
oxide (Lukacs-Kornek et al., 2011), which typically function 
their expansion (Shulman et al., 2013; Gitlin et al., 2014) and 
unrestrained TFH numbers are associated with autoimmunity 
and self-reactive B cells (Pratama and Vinuesa, 2014). This is 
likely to contribute to the development of lymphoid hyper-
plasia in older TP/ mice (Kabashima et al., 2003), perhaps 
owing to excessive immune reactions to commensals in line 
with our observation of increased MLN size in these mice.
Immunoregulatory mechanisms need to be carefully bal-
anced to simultaneously allow for a forceful adaptive immune 
response against pathogens to develop, while protecting the 
Figure 4. Increased numbers of TFH in the absence of TP in OT-II CD4+ T cells. (A–H) WT and TP/ OT-II CD4+ T cells were adoptively transferred 
separately (A–D and F–H) or combined (E) into CD45.1+ WT mice before immunization with OVA/CFA and analyzed on day 8 by flow cytometry. (A) Flow 
cytometry after pregating on CD44high CD62Llow lymphocytes. Numbers indicate the percentage of circled CD45.2+ cells. (B) Percentage of adoptively 
transferred CD45.2+ T cells as pregated in A. (C) PD-1 and CXCR5 expression on transferred WT and TP/ OT-II T cells (red), with numbers indicating per-
cent per quadrant field. CD4+ T cells from a nonimmunized mouse serve as negative control (blue). (D) Percentage of PD-1high CXCR5high CD45.2+ WT or 
TP/ OT-II CD4+ T cells on day 8 after OVA/CFA immunization. Shown is one of three experiments, pooling TFH from spleens and PLNs of 3–4 mice on day 8 
after OVA/CFA immunization. (E) Flow cytometric analysis of intracellular bcl-6 expression (blue) in PD-1high CXCR5high WT or TP/ OT-II CD4+ T cells on 
day 8 after OVA/CFA immunization. As negative control, we plotted the endogenous CD45.1+ CD4+ cell signal (red), which gave an overlapping labeling as 
the isotype control (not depicted). (F) Flow cytometric analysis of intracellular IL-21 expression (blue) in CXCR5high WT or TP/ OT-II CD4+ T cells on day 8 
after OVA/CFA immunization. As negative control, we plotted the CD45.1+ CD4+ cell signal from a nonimmunized mouse (red), which gave an overlapping 
labeling as the isotype control (not depicted). (G) Flow cytometry plots of B220+ cells containing GL-7+ CD95+ GC B cells in WT or TP/ OT-II T cell recipi-
ent mice on day 8 after OVA/CFA immunization with numbers indicating percent per quadrant field. (H) Percentage of GC B cells in WT or TP/ OT-II  
T cell recipient mice 8 d after OVA/CFA immunization in PLNs and spleen. Each dot represents one mouse. Data are representative of three (A–F) or pooled 
from two (H) independent experiments with a total of 9–10 and 5–6 mice, respectively, and analyzed using Mann-Whitney test (B, D, and H). Bars indi-
cate mean. *, P < 0.05; **, P < 0.01.
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DCs, neutrophils, and macrophages, makes a paracrine action 
mode likely and provides the adaptive immune system with an 
additional layer of quality control. TXA2-induced chemokine-
sis and disruption of T cell–DC interactions is likely transmit-
ted by G12/13-triggered activation of the Rho guanine 
exchange factor (GEF) lsc (Harenberg et al., 2005). The result-
ing rise of Rho-GTP then acts on mDia1 to induce cyto-
skeletal changes and chemokinesis (Sakata et al., 2007). In line 
with this hypothesis, we found that I-BOP–induced F-actin 
formation occurred independently of the Rac GEF DOCK2 
(unpublished data), which is critical for actin cytoskeletal attach-
ment of key proteins during IS formation (Sanui et al., 2003; 
Le Floc’h et al., 2013). An attractive model is therefore that 
the balance between DOCK2-Rac–driven IS assembly and 
TP-Rho–mediated disruptive chemokinesis determines suc-
cessful activation of naive CD4+ T cells in reactive PLNs.
In sum, our data help to understand how TP-TXA2 sig-
naling contributes to the generation of high avidity CD4+  
T cell responses, and subsequent high affinity antibody pro-
duction. Similar to T reg cell–mediated CD8+ T cell avidity 
control (Pace et al., 2012), this mechanism involves preventing 
low-avidity T cell–DC interactions. Effector–memory T cells 
and T reg cell subsets decrease TP expression (Kabashima et al., 
2003), which may contribute to their increased sensitivity to 
low pMHC levels on DCs.
MATERIALS AND METHODS
Mice. 4–6-wk-old male C57BL/6 mice were purchased from Janvier (AD 
Horst). LCMV gp61-80–specific Tg(TcrLCMV)Aox (“SMARTA”), C57BL/ 
6-Tg(CAG-EGFP)131Osb/LeySopJ (“Ubi-GFP”), Tg(IghelMD4)4Ccg BCR-
transgenic “MD4” (provided by E. Jacque, National institute for Medical 
Research, London, UK), C57BL/6-Tg(IgkHyHEL10)1Rbr (“SWHEL”; pro-
vided by B. Stolp, University of Heidelberg, Germany), and TP/ mice on 
a C57BL/6 background backcrossed to OT-II TCR transgenic mice specific 
for chicken OVA amino acids 323–339 were bred in the DKF animal facility 
in Bern. Animal work has been approved by the Cantonal Committee for 
Animal Experimentation and conducted according to federal and cantonal 
guidelines. Infection experiments were performed in accordance with federal 
and cantonal guidelines under permission numbers SG13/06 after review 
and approval by the Cantonal Veterinary Office (St. Gallen, Switzerland).
TP antagonist treatment and tetramer staining after OVA-CFA 
immunization. WT or TP/ mice were immunized with chicken OVA/
CFA emulsion (1 mg/ml; Sigma-Aldrich) injected s.c. in a volume of 30 µl/
site in five points closed to inguinal, brachial, and cervical PLNs. In some 
experiments, WT mice were treated with a selective thromboxane receptor 
antagonist, GR32191B (Vapiprost, Sigma-Aldrich), in drinking water for 
9 d, starting 1 d before OVA-CFA immunization, at a dose of 1 mg/kg/d. 
Mice were killed after 8 d, as described above, and tetramer staining was 
performed using the following tetramers (produced by National Institutes 
of Health Tetramer Core Facility, Atlanta, GA), diluted 1:10, for 2 h at 
37°C: PVSKMRMATPLLMQA-PE-control (human CLIP103-117), HAA-
HAEINEA-PE-chicken OVA328-337 (tetramer 1), IINFEKLTEWTSSNV-
MEER-PE-chicken OVA259-277 (tetramer 2), and AAHAEINEA-PE chicken 
OVA329-337 (tetramer 3). All three OVA tetramers gave comparable results in 
flow cytometry.
Neutrophils were depleted by administration of the Ly6G-specific 1A8 
mAb as previously described (Yang and Unanue, 2013), starting on day 1 
before immunization and reinjected every 2 d. An isotype-matched mAb 
(2A3) was used as control. Depletion was verified by flow cytometry.
to suppress immune responses after their onset and act as 
reactive regulators (Germain, 2012), TP operates as tonic regu-
lator to prevent the entry of poorly reactive naive CD4+  
T cells into a developing immune response. Our 2PM data 
revealed that TP-mediated disruption of T cell–DC inter-
actions was gradually overcome by increasing pMHC levels on 
presenting DCs. In line with this observation, we found simi-
lar expansion of WT and TP/ OT-II CD4+ TFH when we 
challenged mice with 10-fold higher OVA levels (unpub-
lished data). Furthermore, infection with the LCMV clone 13, 
which leads to generalized infection and high antigen abun-
dance until day 30 (Oldstone, 2009) resulted in comparable 
ratios of low- and high-avidity CD4+ T cells in WT and 
TP/ mice (unpublished data). An interesting aspect is that 
TXA2 levels are only increased in lymphoid tissue during in-
flammation (Moore et al., 1989), when DCs express high 
levels of co-stimulatory molecules. This suggests that reactive 
PLNs have developed specific mechanisms to avoid low-avidity 
bystander activation without affecting peripheral tolerance 
education of autoreactive T cells in noninflamed PLNs. The 
short half-life (<30 s) of TXA2, presumably produced by 
Figure . TP/ CD4+ T cells preferentially support low-avidity IgG 
responses. WT or TP/ OT-II CD4+ T cells (A and B) or OVA-tet+ WT or 
TP/ CD4+ T cells (C) were adoptively transferred into SMARTA recipients 
before immunization with NP16-OVA/CFA. On day 8 after infection, serum 
was isolated and IgG titers against NP8-BSA and NP41-BSA were measured 
in limited dilution assays. (A) Each line presents a dilution series of serum 
isolated from an individual mouse. (B) IgG titers to NP8- and NP41-BSA 
after transfer of WT or TP/ OT-II CD4+ T cells. (C) IgG titers to NP8- and 
NP41-BSA after transfer of OVA-tet+ WT or TP/ CD4+ T cells. Data in 
B and C are pooled from two independent experiments with 4–5 mice/
group and analyzed by ANOVA with Sidak’s multiple comparison test. 
**, P < 0.01; ***, P < 0.001.
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we injected PE-conjugated anti-CD35 mAb into footpads 18 h before imag-
ing to label FDCs. 2PM of draining popliteal LNs was performed as above 
42–48 h after cell transfer and T–B cell interactions were quantified using 
Volocity software. For analysis of OT-II CD4+ T cell behavior in GC at later 
time points, we transferred 2.5 × 105 GFP-expressing OT-II CD4+ T cells 
into recipient mice, which were immunized with 10 µl of a 3:1 mixture of 
OVA and the adjuvants Montanide ISA25 (final concentration 1.5 mg/ml) 
instead of CFA to avoid excessive foot swelling >3 d after immunization. On 
day 6 after immunization, we analyzed GFP+ OT-II CD4+ T cell migration 
in close apposition to CD35+ FDCs using 2PM of the draining popliteal LNs 
in the presence or absence of the TP antagonist GR32191B.
Flow cytometry for activation markers. WT and TP/ OT-II CD4+ 
T cells were labeled with CFSE or e670 and analyzed 24 h after transfer into 
mice with pMHC-bearing DCs as described for 2PM experiments. Cell sur-
face stainings were performed in staining buffer (PBS containing 1% FCS) 
for 30 min on ice in the dark, with the appropriate combinations of satu-
rating concentrations of the following conjugated mAbs obtained from 
BioLegend: CD25 (3C7), CD69 (H1.2F3), and CD4 (GK1.5). Flow cy-
tometry was performed on a FACSCalibur (BD) and FlowJo software 
(Tree Star) for analysis.
TFH and GC B cell analysis in vivo. 5,000 CD45.1/.2+ WT and CD45.2+ 
TP/ CD4+ T cells were adoptively co-transferred into sex-matched 
CD45.1+ C57BL/6 recipients. Alternatively, 5 × 103 CD45.2+ WT 
or CD45.2+ TP/ CD4+ T cells were separately transferred into sex-
matched CD45.1+ C57BL/6 recipients. The day after cell transfer, mice 
were immunized with chicken OVA/CFA emulsion (1 mg/ml; Sigma-Aldrich) 
injected s.c. in a volume of 30 µl/site in five points closed to inguinal, bra-
chial and cervical PLNs. Recipients were killed after 8 d and cells from cer-
vical, brachial, and inguinal nodes were pooled. Cell surface stainings were 
performed in staining buffer for 30 min, with the appropriate combinations 
of saturating concentrations of the following conjugated mAbs obtained 
from BD, eBioscience, or BioLegend: CD45.2 (104), CD45.1 (A20), GL-7 
(GL-7), PD-1 (29F.1A12), ICOS (C398.4A), OX-40 (OX-86), Ly6C 
(HK1.4), PSGL-1, CD4 (RM4-5), CD45R (RA3-6B2), IgD (11-26c.2a), 
biotinylated CXCR5 (SPRCL5), followed by BV605-streptavidin, and bio-
tinylated CD95, followed by BV421-streptavidin. In some experiments, cells 
were permeabilized using Cytofix/Cytoperm solution (BD) for staining 
with anti–IL-21 mAb (BL25168; BioLegend) or permeabilized with FoxP3 
buffer for bcl6 (K112-91; BD) or FoxP3 (FJK-16S; eBioscience) staining ac-
cording to manufacturer’s instructions to confirm that adoptively transferred 
OT-II CD4+ T cells do not form follicular regulatory T cells (Linterman 
et al., 2011). Stained cells were analyzed with LSRII or FACSCalibur flow 
cytometer (BD). Diva software or CellQuest were used for data acquisition, 
FlowJo software (Tree Star) was used for data analysis.
IgG titration. WT and TP/ mice were immunized with chicken OVA/
CFA emulsion as above, followed by staining with OVA tetramer 2 and 
FITC-conjugated anti-CD4 mAb (1:15,000 dilution to avoid depletion after 
transfer). Low and high tet+ populations were sorted on a FACSAria II Flow 
Cytometer (BD), and 5 × 103 tet+ low WT or TP/ CD4+ T cells were 
separately transferred into sex-matched SMARTA recipients. Owing to low 
numbers of recovered cells, we did not perform adoptive transfer of OVA 
tet+ high CD4+ T cells. Alternatively, 5 × 103 OT-II WT or TP/ CD4+ 
T cells were separately transferred into sex-matched SMARTA recipients. 
The day after cell transfer, mice were immunized with NP16-OVA/CFA 
emulsion (1 mg/ml; 30 µl in five s.c. sites; Biosearch Technologies, Inc.). 
Recipients were killed after 8 d and serum was collected for IgG titration. In 
in brief, Nunc 96-well plates were plated with NP8- or NP41-BSA (0.1 µg/
well; Biosearch Technologies, Inc.) diluted in coating buffer (15 mM car-
bonate buffer, pH 9.6) overnight at 4°C. After washing with washing buffer 
(WB) PBS/0.05% Tween-20 (Sigma-Aldrich), plates were incubated with 
300 µl WB/5% dry milk for 2 h at room temperature. Serum dilutions 
(100 µl/well in 1:5 steps) were added and the plates were incubated for 2 h 
LCMV infection and flow cytometry analysis. LCMV strains Arm-
strong and Clone 13 were propagated on L929 cells and titrated by focus-
forming assay on MC57 cells. Mice were infected i.v. with 103 PFU LCMV 
Armstrong or 107 PFU LCMV Clone 13. For flow cytometry, mice were 
sacrificed on day 8 after injection and single-cell suspensions from spleen and 
inguinal LNs were prepared by mechanical disruption of the organs. Analysis 
of LCMV-specific CD8+ T cells was performed using PE-conjugated tetra-
mers against LCMV gp33-41 and for CD4+ T cell responses gp66-77. We used 
as negative control the LCMV gp precursor6-20 tetramer. MHC class II tetra-
mer staining was performed for 90 min at 37°C. For surface staining, 
allophycocyanin-labeled anti-CD4 (BD) was used. Surface staining was 
performed by incubating samples at 4°C for 20 min 7-Aminoactinomycin D 
(EMD Millipore) was used to discriminate dead cells in flow cytometric 
analysis. Foxp3 staining was performed with the mouse regulatory T cell 
staining kit (eBioscience) using the Foxp3 PE (FJK-16) mAb. Samples were 
analyzed by flow cytometry using FACSCalibur (BD), and data were ana-
lyzed using FlowJo software (Tree Star).
T cell purification. LNs and spleens from WT or TP/ mice were pooled 
and homogenized using a 70-µm cell strainer. Red blood cells were lysed in 
1 ml of a Tris-HCL pH 7.5/0.83% ammonium-chloride buffer for 3 min. 
After washing in CM-R, a medium containing RPMI-1640 supplemented 
with 10% FCS, 100 U/ml penicillin, 100 U/ml streptomycin, 100 mM 
sodium pyruvate, L-glutamine, and nonessential amino acids (NEAAs), we 
used EasySep Mouse T cell Negative Selection kit or Mouse CD4+ T cell 
enrichment kit as described in the manufacturer’s instructions (STEMCELL 
Technologies). Total or CD4+ T cells were negatively isolated in a magnetic 
holder. CD4+ T cell purities were typically >95%.
DC culture and peptide pulsing. BM cell suspensions from Ubi-GFP 
mice were obtained by centrifugation (4,000 rpm, 4 min) of femurs and tibiae. 
BM cells were incubated in 20 ml cultures containing 18 ml CM-R and 
2 ml SP-20 supernatant containing Flt3L for 6 to 9 d until activation with 
1 µg/ml LPS (Sigma-Aldrich) for 24 h and pulsing with OVA peptides for 1 h 
at 37°C. Chicken OVA323-339 (ISQAVHAAHAEINEAGR) and turkey 
OVA324-340 (ISQAAHAAYAEIYEAGR) were obtained from Eurogentec.
2PM of popliteal PLNs. GFP-expressing DCs (2 × 106/mouse) were 
pulsed with indicated concentrations of chicken or turkey OVA peptide and 
injected s.c. in hindfoot of recipient mice 18 h before CD4+ T cell transfer. 
Purified T cells were fluorescently labeled with 2.5 µM CMTMR or 20 µM 
CMAC for 15 min at 37°C, with dyes swapped between experiments. After 
washing, 5 × 106 labeled T cells were injected i.v. into sex-matched 5–10-
wk-old anesthetized C57BL/6 recipient mice surgically prepared to expose 
the right popliteal PLN. 5 or 18–22 h after T cell transfer, 2PM imaging was 
performed using the TrimScope system equipped with a Olympus BX50WI 
fluorescence microscope and a 20× objective (NA 0.95; LaVision Biotec). 
11–16 z-stacks (spacing 4 µm) of 250–300 × 250–300 µm x–y sections were 
acquired every 20 s for 20–30 min. Imaging was performed in the T cell area 
identified by the presence of HEVs labeled using Alexa Fluor 633–conjugated 
MECA-79 (15 µg/mouse). Sequences of image stacks were transformed into 
volume-rendered four-dimensional movies using Volocity software, which 
was also used for semiautomated tracking of cell motility in three dimen-
sions. The average track speed, turning angles (defined as the angle between 
the two velocity vectors before and after a measurement time point) and 
motility coefficient were calculated from the x, y, and z coordinates of cell 
centroids. The arrest coefficient was determined as the percentage per track 
a cell moved slower than 4 µm/min.
For early T–B cell interaction analysis, fluorescently labeled WT and 
TP/ OT-II T cells (3–5 × 106 cells/mouse) were co-transferred i.v. with 
MD4 B cells or SWHEL B cells (3–5 × 106 cells/mouse) into C57BL/6 mice, 
which had been s.c. immunized 12 h before with 20 µl of a 1:1 mixture of 
CFA and chemically coupled HEL-OVA (final concentration 1.2 mg/ml) in 
the hock. To synchronize cell population behavior, we blocked further 
homing 4–10 h after transfer with 100 µg Mel-14/mouse. In some experiments, 
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at 37°C. After washing with WB, biotinylated polyclonal goat anti–mouse 
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Bound antibodies were detected using OPD substrate, and absorbance was 
read at a wavelength of 490 nm. Results were calculated as titer by inter-
polation of absorbance values at a fixed serum dilution into a linear regres-
sion analysis plotting. Owing to the high molar ratio of NP moieties to 
BSA in the NP41-BSA coated plates, low- and high-affinity anti-NP mAbs 
can bind, whereas only high affinity anti-NP mAbs bind to NP8-BSA–
coated plates.
Statistical analysis. Data were analyzed with GraphPad Prism 6 using Mann-
Whitney test or ANOVA-one way test followed by Bonferroni’s or Sidak’s 
multiple comparison test. P values >0.05 were considered not significant.
Online supplemental material. Videos 1–6 show the dynamic inter-
actions of OT-II CD4+ T cells with DCs pulsed with 0.1 µM OVA, 10 µM 
OVA, and 10 µM tOVA. Fig. S1 shows the gating strategies used for flow 
cytometric analysis. Online supplemental materials are available at http://
www.jem.org/cgi/content/full/jem.20140137/DC1.
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 Figure S1. Gating strategies for fl ow cytometric analysis. (A) Gating strategy of OVA tet + CD4 + T cells after OVA/CFA immunization. Numbers indi-
cate percentages of gated populations. (B) Percentages of control and OVA tet + CD4 + T cells in draining PLNs of WT and TP   /   mice. (C) Gating strategy 
for fl ow cytometric analysis of gp 66-77 tet + CD4 + T cells after LCMV Armstrong infections. (D) Gating strategy of adoptively transferred CD4 + CD44 high CD-
62 low CD45.2 + WT or TP   /   OT-II CD4 + T cells on day 8 after OVA/CFA immunization. (E) Gating strategy for fl ow cytometric analysis of germinal center B 
cells on day 8 after OVA/CFA immunization. (F) Sorting strategy by fl ow cytometry for low and high OVA tet + CD4 + T cells on day 8 after OVA/CFA-immu-
nization of WT and TP   /   mice. Numbers indicate percentages of gated populations. Owing to low numbers of recovered high OVA tet + CD4 + T cells, we 
did not transfer these cells into SMARTA mice. Data in B are pooled from two independent experiments with 4–8 mice/group and analyzed using a Krus-
kal-Wallis test. *, P < 0.05; **, P < 0.01. 
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 Video 1.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells and DCs (green) pulsed with 
0.1 μM OVA . Selected WT and TP   /   OT-II CD4 + T cells tracks are shown in blue and red, respectively. HEVs are labeled brown. 
Time is shown in minutes and seconds. Bar, 25 μm. 
  
 Video 2.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells and DCs (green) pulsed with 
10 μM OVA. Selected WT and TP   /   OT-II CD4 + T cells tracks are shown in blue and red, respectively. Time is shown in min-
utes and seconds. Bar, 30 μm. 
  
 Video 3.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells interacting with DCs (green) 
pulsed with 0.1 μM OVA. Interactions with DCs are labeled with arrowheads for WT and arrows for TP   /   OT-II CD4 + T cells, 
respectively. An HEV (brown) is seen in the top left corner. Time is shown in minutes and seconds. Bar, 15 μm. 
  
 Video 4.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells interacting with DCs (green) 
pulsed with 10 μM OVA. Interactions are labeled as in Video 3. An HEV (brown) is seen in the bottom. Time is shown in min-
utes and seconds. Bar, 15 μm. 
  
 Video 5.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells and DCs (green) pulsed with 
10 μM tOVA . Selected WT and TP   /   OT-II CD4 + T cells tracks are shown in blue and red, respectively. HEVs are labeled 
brown. Time is shown in minutes and seconds. Bar, 30 μm. 
  
 Video 6.  2PM image sequence showing WT (blue) and TP   /   (red) OT-II CD4 + T cells interacting with DCs (green) 
pulsed with 10 μM tOVA. Interactions are labeled as in video 3. Time is shown in minutes and seconds. Bar, 10 μm. 
